Twelve-year follow-up study of hepatitis B immunization of Senegalese infants.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(05)80404-0PMID 7989718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Random-effects models, for longitudinal data using Gibbs sampling.

  1993cited by this paper
• Scheduling of revaccination against hepatitis B virus.

  1991cited by this paper
• Immunogenicity of hepatitis B vaccine simultaneously administered with the expanded programme on immunisation (EPI)

  1990cited by this paper
• Hepatitis B vaccine in infants from an endemic area: Long‐term anti‐HBs persistence and revaccination

  1987cited by this paper
• Hepatitis B immunization of infants with a reduced number of injections: study of a schedule of three injections at three-month intervals.

  1987cited by this paper
• Age‐ and sex‐related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal)

  1987cited by this paper
• Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).

  1986cited by this paper
• Clinical trial of hepatitis B vaccine in a simplified immunization programme.

  1986cited by this paper
• Hepatitis B immunization of newborns according to a two dose protocol.

  1986cited by this paper
• Viral hepatitis and liver disease

  1984cited by this paper
• Immunogenic effect of hepatitis B vaccine in children: Comparison of two‐and three‐dose protocols

  1984cited by this paper
• Active immunization against hepatitis B in an area of high endemicity. Part I: Field design.

  1981cited by this paper
• Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal).

  1981cited by this paper

• Effect of hepatitis B vaccination on HBV-infection among school children in Yaounde; ten years after the introduction of HBV vaccine into routine Immunization Program in Cameroon

  2024cites this paper
• Overview of Hepatitis B Vaccine Non-Response and Associated B Cell Amnesia: A Scoping Review

  2024cites this paper
• Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

  2022cites this paper
• Hepatitis B Vaccines

  2021cites this paper
• Hepatitis B Vaccination Impact and the Unmet Need for Antiviral Treatment in Blantyre, Malawi

  2021cites this paper
• Modeling adaptive response profiles in a vaccine clinical trial

  2020cites this paper
• Childhood Immunizations

  2020cites this paper
• Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia

  2020cites this paper
• Clinical and Serological Findings of Madariaga and Venezuelan Equine Encephalitis Viral Infections: A Follow-up Study 5 Years After an Outbreak in Panama

  2020cites this paper
• Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level

  2019cites this paper
• Mother‐to‐child transmission of hepatitis B: What more needs to be done to eliminate it around the world?

  2019cites this paper
• Evaluation of research on interventions aligned to WHO ‘Best Buys’ for NCDs in low-income and lower-middle-income countries: a systematic review from 1990 to 2015

  2018cites this paper
• 25 – Hepatitis B Vaccines

  2018cites this paper
• The Effect of Oral Levamisole Co-administration on the Level of Immune Response to Hepatitis B Vaccine in Healthy Individuals: A Randomized Clinical Trial.

  2017cites this paper
• y adolescentes: ¿revacunar?

  2016cites this paper
• 24 year outcomes of hepatitis B vaccination in Hangzhou, China

  2015cites this paper
• Can healthcare solutions form part of the problem? Senegal's dichotomized approach to hepatitis B prevention

  2015cites this paper
• Reasons why West Africa continues to be a hotbed for hepatocellular carcinoma

  2015cites this paper
• Hepatitis B Vaccination and Associated Oral Manifestations: A Non-Systematic Review of Literature and Case Reports

  2014cites this paper
• Problem of hepatocellular carcinoma in West Africa.

  2014cites this paper
• Repeated vaccinations do not improve specific immune defenses against Hepatitis B in non-responder health care workers.

  2014cites this paper
• Correlates of risk of TB disease in infants with differential response to BCG vaccination

  2014cites this paper
• 15 – Hepatitis B vaccines

  2013cites this paper
• Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults.

  2013cites this paper
• UK vaccination schedule: persistence of immunity to hepatitis B in children vaccinated after perinatal exposure

  2013cites this paper
• Determinants of Long-term Protection After Hepatitis B Vaccination in Infancy: A Meta-analysis

  2013cites this paper
• Immune Response of Ghanaian Children to the Hepatitis B Antigen in the Pentavalent (DPT-HepB-Hib) Vaccine in Accra

  2013cites this paper
• Serologic markers for HBV, HCV and HIV in immigrants visiting the Athens' polyclinic of 'Doctors of the World - Greece'.

  2013cites this paper
• Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

  2012cites this paper
• Recombinant Hepatitis B Vaccine (Engerix-B®)

  2012cites this paper
• lobal epidemiology of hepatitis B virus infection : New estimates of age-specific

  2012cites this paper
• Prevention of hepatocellular carcinoma: a concise review of contemporary issues.

  2012cites this paper
• A Study on Immune Response of Hepatitis B Vaccine Among Medical Interns

  2012cites this paper
• The effects of booster vaccination of hepatitis B Vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination

  2011cites this paper
• Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.

  2011cites this paper
• Seroprevalence of markers for hepatitis B viral infection.

  2011cites this paper
• Switched memory B cells maintain specific memory independently of serum antibodies: The hepatitis B example

  2011cites this paper
• Why is the Tumour Different in Africa

  2011cites this paper
• antibodies: the Hepatitis B example

  2011cites this paper
• Strategies for global prevention of hepatitis B virus infection.

  2010cites this paper
• InfectionPrevention of Hepatitis B Virus Update on Diagnosis, Management,

  2010cites this paper
• Correlates of Protection Induced by Vaccination

  2010cites this paper
• Vaccination of children--a systematic review.

  2010cites this paper
• Recombinant HBsAg Vaccine in Persons with HIV: Is Seroconversion Sufficient for Long-term Protection?

  2010cites this paper
• ANTIBODY TO HEPATITIS B SURFACE ANTIGEN (ANTI-HBS)

  2009cites this paper
• Hepatitis B immunization strategies: timing is everything

  2009cites this paper
• Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan.

  2009cites this paper
• Chapitre 19 – Acquisitions récentes en matière de vaccinations et vaccins du futur

  2009cites this paper
• Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention.

  2009cites this paper
• Investigation (In Vivo and In Vitro) of Booster Dose Vaccine Requirement for Long-Term Protection against Hepatitis B Virus Infection

  2009cites this paper
• SEROLOGICAL IMMUNE STATUS OF HEPATITIS-B IN VACCINATED HEALTHY INDIVIDUALS

  2008cites this paper
• A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d'Ivoire.

  2008cites this paper
• HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.

  2008cites this paper
• The global impact of vaccination against hepatitis B: a historical overview.

  2008cites this paper
• Prevention of viral hepatitis (B and C) reassessed.

  2008cites this paper
• Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.

  2008cites this paper
• Vacunación contra Hepatitis B: veinte años Después

  2007cites this paper
• Seroprevalence of Hepatitis‐B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis‐B vaccination program

  2007cites this paper
• Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination.

  2007cites this paper
• Waning‐off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post‐implementation of Taiwan’s national hepatitis B vaccination programme

  2007cites this paper
• Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence

  2007cites this paper
• Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago.

  2007cites this paper
• Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.

  2007cites this paper
• Low seroprevalence of hepatitis B surface antibody among nursing students in Taiwan: an implication for boosting.

  2007cites this paper
• Long-term protection against carriage of hepatitis B virus after infant vaccination.

  2006cites this paper
• Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

  2006cites this paper
• Health Service Interventions for Cancer Control in Developing Countries

  2006cites this paper
• Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan.

  2006cites this paper
• بررسی میزان سرمی anti-HBs در کودکانی که در دوره نوزادی با واکسن نوترکیب هپاتیت B واکسینه شده اند

  2006cites this paper
• A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

  2005cites this paper
• Long-Term Follow-Up of Hepatitis B Surface Antibody Levels in Subjects Receiving Universal Hepatitis B Vaccination in Infancy in an Area of Hyperendemicity: Correlation between Radioimmunoassay and Enzyme Immunoassay

  2005cites this paper
• Hepatitis B vaccine boosters: Is there a clinical need in high endemicity populations?

  2005cites this paper
• Introduction en Suisse de la vaccination généralisée contre l'hépatite B

  2005cites this paper
• Einführung der generellen Hepatitis-B-Impfung in der Schweiz

  2005cites this paper
• Persistence of Antibody to Hepatitis B and Protection From Disease Among Alaska Natives Immunized at Birth

  2005cites this paper
• Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.

  2005cites this paper
• 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children.

  2004cites this paper
• Waning immunity to plasma‐derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination

  2004cites this paper
• Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth.

  2004cites this paper
• Hepatitis B vaccination in a hyper-endemic tribal community from India: assessment after three years.

  2004cites this paper
• Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

  2003cites this paper
• Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

  2003cites this paper
• Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination

  2003cites this paper
• Hepatitis B vaccines.

  2003cites this paper
• Safety and immunogenicity of a combination diphtheria-tetanus toxoids-acellular pertussis-hepatitis B vaccine administered at two, four and six months of age compared with monovalent hepatitis B vaccine administered at birth, one month and six months of age

  2002cites this paper
• Topics in Modeling Multilevel and Longitudinal Data

  2002influential citation
• Hepatitis B control in Europe by universal vaccination programmes: The situation in 2001

  2002cites this paper
• Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

  2002cites this paper
• Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds.

  2002cites this paper
• Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination

  2002cites this paper
• Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response

  2001cites this paper
• Immunologic correlates of protection induced by vaccination

  2001cites this paper
• Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study.

  2001cites this paper
• Títulos de anti-HBs tras un programa de vacunación en niños y adolescentes: ¿revacunar?

  2001cites this paper
• Considerations for hepatitis B as part of a combination vaccine

  2001cites this paper
• Repeated‐measures models to evaluate a hepatitis B vaccination programme

  2001cites this paper
• Analysis of the relationship between immunogenicity and immunity for viral subunit vaccines

  2001cites this paper
• Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory.

  2000cites this paper
• Infant and adolescent hepatitis B immunization up to 1999: a global overview.

  2000cites this paper
• Humoral immune response following hepatitis B vaccine booster dose in children with and without prior immunization.

  2000cites this paper